We're increasing our fair value estimate for Halma to GBX 2,800 from GBX 2,600. We expect the robustness of Halma’s end markets combined with its strong pricing power will deliver 8% annualized ...
Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.